Surgery Center Valuation: A Complete Guide to ASC Multiples and Methods

Understanding surgery center valuation is essential for investors, healthcare professionals, and ASC owners navigating the complex landscape of ambulatory surgery center transactions. Whether you’re considering buying, selling, or partnering with an ASC, knowing how to accurately determine value using industry-standard multiples can mean the difference between a profitable transaction and leaving money on the table.

This comprehensive guide explores the intricacies of surgery center valuation, from EBITDA multiples to the key factors that influence ASC worth in today’s healthcare market.

Nechay Advisors provides ASC valuations for physician-owners, investors, and healthcare professionals nationwide. Whether you need a valuation for a physician buy-in, partner buyout, or full sale, we deliver credible, defensible appraisals backed by deep ambulatory surgery center experience. Schedule a free consultation to discuss your ASC valuation needs.

Key Takeaways

• Surgery center valuation multiples typically range from 2x to 8x EBITDA, depending on size, specialty mix, payer composition, and whether you’re valuing a controlling or minority interest.
• EBITDA multiples are the most common transaction metric, though formal fair market value appraisals using multiple methodologies are equally prevalent in practice.
• Size, location, payer mix, specialty focus, and operational efficiency significantly impact valuation multiples.
• Multi-specialty centers generally command higher multiples than single-specialty facilities (6x–8x vs. 5x–8x for controlling interests).
• Controlling interests trade at substantial premiums over minority positions.
• Heavy out-of-network revenue concentration can eliminate most buyers or warrant significant multiple reductions.
• In Certificate of Need (CON) states, existing ASCs often command premium valuations due to barriers to entry.

Table of Contents

• What Are Surgery Center Valuation Multiples?
• Formula Method vs. Fair Market Value Appraisals
• Current ASC Valuation Multiples: Market Data and Ranges
• The Critical Role of EBITDA in Surgery Center Valuation
• Selecting the Right EBITDA Measure
• Complexities in Determining Valuation Multiples
• Factors That Influence Surgery Center Valuation
• Impact of Size on Valuation Multiples
• Comprehensive Calculation and Interpretation
• Comparing Different Valuation Approaches
• Industry Standards and Benchmarks
• Key Considerations When Valuing Surgery Centers
• The Value of Consulting Valuation Experts
• Frequently Asked Questions

What Are Surgery Center Valuation Multiples?

Surgery center valuation multiples are financial ratios used to determine the market value of ambulatory surgery centers by comparing their financial performance to established benchmarks. These multiples provide a standardized method for evaluating ASCs against comparable facilities and transaction data.

One of the most common approaches to surgery center valuation involves applying a multiple to the center’s Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). This methodology lets buyers, sellers, and investors quickly assess value based on the center’s earning potential.

Understanding surgery center valuation multiples requires examining several key components:

Market Value of Invested Capital (MVIC): This represents the total value of a surgery center, including both equity and interest-bearing debt. The formula for calculating valuation using multiples is:

MVIC = EBITDA × Valuation Multiple

In practice, you’ll also see valuations expressed in terms of Enterprise Value (EV). The key difference: MVIC treats cash as an operating asset included in the value, while Enterprise Value excludes cash (and is calculated as equity value plus debt minus cash). Understanding which metric is being used prevents confusion when comparing deal terms or valuation reports.

Financial Metrics: While EBITDA is most common, valuation multiples can also be based on revenue, net income, or cash flow. Each metric serves different purposes depending on the ownership structure and transaction type.

Formula Method vs. Fair Market Value Appraisals

In practice, ASC ownership transactions use one of two approaches to determine value:

Formula Method: Many ASC operating agreements specify a predetermined formula for buy-ins and buyouts. Shareholders agree in advance on a financial metric (e.g., EBITDA) and a fixed multiple (e.g., 4x or 5x). When a transaction occurs, the parties simply apply the formula to current financials. This approach offers simplicity and predictability — everyone knows the rules upfront, and there’s no negotiation over methodology.

However, formula methods have drawbacks. A fixed multiple doesn’t account for changes in market conditions, shifts in case volume, payer contracts, or operational improvements. A center that’s growing rapidly — or one facing a drop in utilization — will be misvalued using a formula approach. The formula method is a pricing mechanism; it doesn’t consider the actual return (think distributions) that the investor will receive from ASC ownership.

Fair Market Value Appraisal: Other ASCs require an independent appraisal for each transaction. A certified appraiser analyzes the center’s financials, market position, and comparable transactions to determine value at the time of the buy-in or buyout. This approach captures current market conditions and center-specific factors that a fixed formula might miss.

Both approaches are common. Formula methods reduce transaction friction but can produce values that diverge from actual market conditions over time. Appraisals add cost and complexity but provide a more accurate picture of what the interest is actually worth.

Current ASC Valuation Multiples: Market Data and Ranges

ASC valuation multiples vary based on two primary factors: specialty composition and control level. Single-specialty centers typically trade at lower multiples than multi-specialty facilities, and controlling interests command substantial premiums over minority positions.

Center type	Minority interest	Controlling interest
Single-specialty ASC	3x–5x EBITDA	5x–8x EBITDA
Multi-specialty ASC	4x–6x EBITDA	6x–8x EBITDA

Disclaimer: The valuation multiples presented here are for educational purposes only and do not constitute valuation advice or represent the professional opinion of Nechay Advisors or its analysts. For advice specific to your center, consult a qualified valuation professional.

For example, on its earnings call, Surgery Partners has publicly stated it deploys capital at approximately an 8x EBITDA multiple for ASC acquisitions. Given that it generally structures its ASC partnerships as either a majority owner or with buy-up options to acquire controlling interest in the future, this aligns with the upper end of the ranges above.

The control premium is significant. Buyers acquiring majority ownership gain the ability to direct strategy, operations, and distributions — and they pay accordingly. Minority interest transactions consistently close at lower multiples, reflecting the limited influence that comes with a non-controlling stake.

Two additional factors can meaningfully shift multiples. In states with Certificate of Need (CON) requirements, existing ASCs often command premiums due to regulatory barriers that limit new competition. Conversely, heavy reliance on out-of-network revenue can dramatically reduce value — or eliminate most buyers entirely. Centers with substantial out-of-network exposure often see significant multiple reductions, and many institutional buyers simply won’t pursue them.

Wondering where your center falls in these ranges? A confidential valuation consultation is free and comes with no obligation. Schedule a call.

The Critical Role of EBITDA in Surgery Center Valuation

EBITDA serves as the cornerstone of surgery center valuation because it provides a clear picture of operational performance independent of capital structure, tax situations, and non-cash accounting items. When investors and buyers evaluate an ASC, they focus on EBITDA as a proxy for cash-generating ability.

Why EBITDA Matters in ASC Valuations

EBITDA eliminates variables that don’t reflect the day-to-day operational success of a surgery center:

• Interest expenses are removed because the acquiring entity will have its own financing structure. Two identical surgery centers with different debt loads have the same operational value.
• Taxes are excluded because tax situations vary by entity structure, jurisdiction, and planning strategies. The buyer’s tax position will differ from the seller’s, so pretax earnings provide a cleaner comparison.
• Depreciation and amortization are non-cash expenses that depend on accounting elections and whether prior acquisitions created amortizable intangibles. Two operationally identical centers can show very different D&A figures; removing them allows an apples-to-apples comparison of cash-generating ability.

Controlling Interests vs. Non-Controlling Ownership

The structure of ownership significantly impacts how EBITDA translates into surgery center valuation.

Controlling interests hold majority stakes (typically 51% or more) and exercise significant influence over strategic decision-making, operational policies, capital allocation, and management selection. They typically command premium valuations because they offer the buyer full operational control and the ability to implement strategic changes.

Non-controlling (minority) interests have limited influence over day-to-day operations, major strategic decisions, distribution policies, and exit timing. They often face substantial discounts compared to controlling interests — known as discounts for lack of control (DLOC) — reflecting the diminished value of minority positions.

Selecting the Right EBITDA Measure

Choosing the appropriate EBITDA measure is perhaps the most nuanced aspect of surgery center valuation. Not all EBITDA calculations are created equal, and selecting the wrong measure can significantly misrepresent a center’s true value.

Types of EBITDA in ASC Valuations

• Historical EBITDA is based on actual past performance, typically averaging the previous 12–24 months. This approach is straightforward but may not reflect current conditions or recent operational improvements.
• Normalized EBITDA adjusts historical EBITDA for one-time events, unusual expenses, or revenues that won’t continue — removing one-time legal settlements or insurance proceeds, adjusting above- or below-market management compensation, eliminating ownership-change expenses, and normalizing supply costs to market rates.
• Projected EBITDA uses forward-looking estimates based on expected future performance — used when recent changes (new surgeon partnerships, expanded services, payer contracts, new management fees) haven’t yet fully impacted historical results.
• Pro forma EBITDA reflects the EBITDA a center would generate under new ownership or operational assumptions. It’s critical for platform acquisitions where buyer synergies will materially impact performance.

Key Considerations in EBITDA Selection

The procedural mix within a surgery center significantly influences which EBITDA measure is most appropriate. Centers heavily weighted toward high-margin specialties may show different trajectories than those performing lower-margin procedures.

Ownership structures also dictate calculation approaches. Physician-owned centers with investors who also serve as surgeons require careful normalization of physician compensation to separate reasonable compensation from distributions of earnings.

Recent acquisitions or partnerships can complicate EBITDA measurement. If a center recently acquired another facility or added new physician partners, historical EBITDA may not reflect the combined entity’s true earning potential. Likewise, payer-contract changes — new in-network contracts or rate renegotiations mid-period — require projection or pro forma adjustments to accurately represent ongoing earnings capacity.

Selecting the right EBITDA measure is one of the most consequential decisions in any ASC valuation — and one of the most common sources of dispute between buyers and sellers. Nechay Advisors has extensive experience normalizing and adjusting ASC financials to arrive at a defensible, well-supported value conclusion.

Complexities in Determining Valuation Multiples

Determining accurate valuation multiples for ASCs involves navigating numerous complexities beyond simple financial formulas. These intricacies stem from the unique characteristics of the healthcare industry and the specific operational dynamics of ambulatory surgery centers.

Regulatory and Compliance Factors

• Certificate of Need (CON) states: In states requiring CON approval for new surgery centers, existing ASCs may command premium valuations due to barriers to entry. Limited competition created by CON laws can justify multiples at the higher end of typical ranges.
• Stark Law and Anti-Kickback compliance: Valuation multiples must account for compliance with federal regulations governing physician ownership and referrals. Centers with ownership structures that create compliance risks may face discounted multiples.
• State-specific regulations: Some states impose additional requirements, such as minimum physician ownership percentages or restrictions on the corporate practice of medicine. These can impact both marketability and valuation.

Management Agreements and Their Impact

Management service agreements (MSAs) between ASCs and management companies significantly influence value. Centers paying fair market value management fees (typically 3–6% of net revenue) generally receive full valuation multiples. Centers with above-market fees require EBITDA normalization — adding back the excess to reflect true operational performance — though if the agreement can’t be easily modified, the multiple itself might be reduced. And where a management company provides significant infrastructure, technology, and operational support, the center may be more dependent on that relationship, potentially affecting multiples if the relationship wouldn’t survive an ownership change.

Procedural Mix and Specialty Concentration

• Specialty concentration risk: Single-specialty centers face greater risk if that specialty experiences reimbursement cuts, regulatory changes, or shifts in care delivery — typically resulting in slightly lower multiples than well-diversified multi-specialty centers.
• High-margin procedure mix: Centers performing a high percentage of premium procedures (such as total joints in orthopedics or complex retinal surgeries in ophthalmology) may justify higher multiples due to superior unit economics.
• Payer mix quality: The distribution between commercial, Medicare, and Medicaid cases significantly impacts both EBITDA and multiples. Centers with 70%+ commercial payer mix typically command premium valuations.

Factors That Influence Surgery Center Valuation

Beyond the basic mathematics of multiples, numerous factors influence the ultimate valuation of ambulatory surgery centers. Understanding these elements helps both buyers and sellers navigate negotiations with realistic expectations.

Revenue Streams and Growth Trends

Consistent revenue growth demonstrates an ASC’s competitive position and market demand. Centers demonstrating 5–10% annual revenue growth typically receive higher multiples than flat or declining facilities. Increasing case volumes indicate growing surgeon satisfaction and market-share gains — even if average reimbursement per case stays flat, volume growth drives value. And recently recruited surgeons who haven’t yet reached full productivity represent future EBITDA growth not reflected in historical numbers; buyers will pay for this documented pipeline through higher multiples or pro forma adjustments.

Operational Efficiency Metrics

Operational excellence translates to higher valuation through both improved EBITDA and multiple expansion. High-performing ASCs maintain operating margins of 30–45%, and centers consistently above 35% typically command top-quartile multiples within their size category. Efficient staffing models that optimize throughput without compromising quality (measured by cases per OR per day and revenue per FTE) and optimized supply costs both signal the management competence buyers reward.

Market Position and Competitive Dynamics

In markets with few competitors or high barriers to entry, existing surgery centers command premium multiples — particularly in CON states or markets where major health systems control most hospital-based outpatient surgery capacity. ASCs facing limited competition from hospital outpatient departments enjoy stronger negotiating positions with payers and can maintain pricing power. And where insurance networks have limited ASC capacity, existing in-network centers become essential to payer networks, creating significant strategic value.

Payer Relationships and Contracting

The strength and terms of an ASC’s payer contracts fundamentally drive its valuation. In-network ASCs with major commercial payers are significantly more marketable and typically command higher valuations — network access provides volume stability, reduces patient price sensitivity, and lowers collection risk. Out-of-network centers face a narrower buyer pool, and many buyers won’t consider facilities with substantial out-of-network revenue. Long-term contracts (3–5 years) with major payers provide revenue visibility, while annual or month-to-month arrangements depress multiples. And even with in-network status, rate adequacy matters enormously — centers with rates at or above Medicare demonstrate strong negotiating positions.

Facility and Equipment Considerations

Physical assets and their condition affect value through several channels. Facility ownership vs. leasing can add real estate value separate from operational value — though owned real estate can complicate deals if buyers don’t want it included. Modern, well-maintained equipment indicates lower near-term capital requirements, while aging equipment creates hidden liabilities. All necessary licenses and accreditations (AAAHC, AAAASF, or Joint Commission) must be current and transferable, and expansion capacity for additional operating rooms represents valuable growth optionality, particularly for centers operating near capacity.

Impact of Size on Valuation Multiples

Size is one of the most significant drivers of valuation multiples in the ASC market. Larger centers consistently command higher multiples than smaller facilities, driven by several economic and strategic factors.

Economies of Scale

Larger centers achieve operational efficiencies that smaller facilities cannot match. Fixed-cost absorption improves as administrative overhead, management fees, and compliance costs represent a smaller percentage of revenue — a $15 million ASC spreads these costs across far more procedures than a $3 million center. Purchasing power lets large centers negotiate better pricing on supplies and equipment, and staffing efficiency improves as multi-OR centers share pre-op, recovery, and administrative personnel across operating rooms.

Buyer Universe Expansion

Valuation increases with size partly because larger centers attract more potential buyers. Many private equity funds and management companies have minimum EBITDA requirements ($1.5–2 million is common), so centers below these thresholds have limited buyer pools. Large centers can also serve as platform acquisitions, which typically command 0.5–1.0x higher multiples than add-on acquisitions, and lenders’ preference for larger, more stable cash flows means better debt financing that allows buyers to pay more.

State Regulatory Environments

State-level regulations create significant variation across markets. CON states like Georgia, North Carolina, and South Carolina restrict new ASC development, so existing centers command an estimated 10–20% higher multiples due to protected market positions. Ownership restrictions can depress valuations where buyers must maintain complex structures, and greater licensing flexibility enhances value by enabling easier service-line expansion.

Comprehensive Calculation and Interpretation

Accurately calculating surgery center valuation requires systematic analysis of historical performance, market positioning, and future potential. While the basic formula (EBITDA × Multiple) appears simple, proper execution demands rigorous financial analysis.

Step-by-Step Valuation Calculation

1. Determine base EBITDA. Start with historical EBITDA, typically averaging the most recent 12–24 months. For centers with seasonal variation or recent changes, weighted averages favoring recent periods may be appropriate.
2. Normalize EBITDA. Adjust for non-recurring expenses (legal settlements, equipment write-offs), owner/physician compensation above or below market, related-party transactions at non-market terms, and excess or deferred maintenance.
3. Apply pro forma adjustments. Incorporate documented changes not yet reflected in historical results — new payer contracts with known rate changes, recently recruited physicians with projected case volumes, operational improvements already implemented, and eliminated services.
4. Select the appropriate multiple. Base it on center size and EBITDA level, specialty mix and concentration, market position, payer mix and contract quality, recent comparable transactions, and control level.
5. Calculate enterprise value. Enterprise Value = Normalized/Pro Forma EBITDA × Selected Multiple.
6. Adjust for assets and liabilities. Add excess cash and marketable securities; subtract interest-bearing debt and unfunded liabilities; consider working-capital requirements.

Interpreting Valuation Results

The calculated valuation represents a starting point for negotiations rather than a definitive price. Professional valuations typically present ranges (e.g., $12–14 million) rather than point estimates, reflecting uncertainty in assumptions and multiple selection. Minority interests typically require discounts for lack of control, and minority interests in closely held ASCs face marketability discounts often warranting 25–40% reductions from a pro-rata share of value. Finally, strategic buyers may pay premiums for unique synergies, network gaps filled, or competitive positioning achieved through the acquisition.

Comparing Different Valuation Approaches

While EBITDA multiples are common in ASC valuations, other methodologies provide important perspectives and validation points. Understanding these alternatives enhances confidence in valuation conclusions.

Transaction Multiples Approach

The transaction multiples methodology examines recent sales of comparable surgery centers to derive market-based multiples. Its strengths are that it reflects actual prices paid by willing buyers and sellers, incorporates current market sentiment and capital availability, and is most directly comparable to the subject center. Its limitations are limited publicly available ASC transaction data, difficulty finding truly comparable transactions, and transaction-specific factors that may not apply.

While EBITDA multiples dominate, other metrics appear in certain contexts: revenue multiples (typical range 0.8x–1.7x revenue) and SDE multiples for smaller, owner-operated centers (typical range 3.2x–7.3x SDE). These are less common but useful reference points when EBITDA-based analysis is problematic.

Cost Approach Valuation

The cost approach estimates value based on the replacement cost of physical assets and the investment required to replicate the operating center — calculating the cost to replicate leasehold improvements, adding replacement cost of medical and office equipment, including working capital, adding regulatory approval costs and identifiable intangibles (assembled workforce, payer contracts, favorable leases), then applying depreciation for obsolescence and subtracting liabilities. It provides a floor value for established centers and is important in marital dissolutions or tax disputes, but it doesn’t reflect earning power and typically produces values below market multiples for profitable centers. In practice, it serves mainly as a sanity check.

Discounted Cash Flow (DCF) Model

The DCF approach values a center based on projected future cash flows discounted to present value — projecting 5–10 years of detailed cash flows, calculating a terminal value, and discounting everything using a weighted average cost of capital (WACC). It’s the most theoretically sound method, captures center-specific growth trajectories, and explicitly accounts for risk, but it’s highly sensitive to assumptions and requires detailed forecasting often unavailable for smaller centers. DCF is most valuable for large, complex centers with documented growth initiatives or significant capital programs.

Reconciling Multiple Approaches

Best practice involves applying multiple methodologies and reconciling the results. When market multiples, DCF, and (where relevant) the cost approach all produce values within 15–20% of each other, confidence in the conclusion strengthens. More weight should go to the approaches most relevant to the transaction context, and sensitivity testing — varying multiples, growth rates, and discount rates within reasonable ranges — demonstrates the valuation’s robustness.

Industry Standards and Benchmarks

Understanding industry benchmarks helps contextualize individual valuations and supports negotiations with data-backed expectations.

The ASC industry has experienced significant consolidation over the past decade. Private equity investment has driven multiple expansion, particularly for high-quality, platform-scale centers. Health systems increasingly view ASCs as strategic assets and sometimes pay premiums above private-market multiples. And major management company platforms continue aggressive acquisition strategies, providing consistent buyer demand.

Different ownership models show distinct patterns. Traditional physician-owned centers typically trade at mid-range multiples unless exceptional performance justifies premiums. Health-system joint ventures often show lower profitability due to hospital infrastructure costs but may receive strategic premiums. And centers where management companies hold controlling stakes sometimes trade at lower multiples relative to physician-controlled centers due to physician-retention risk.

Key Considerations When Valuing Surgery Centers

In transaction contexts, valuation analysis extends beyond financial calculations into operational and legal due diligence. While a formal appraisal focuses on determining fair market value, buyers and sellers must also evaluate factors that could affect deal execution or post-closing performance.

Due Diligence Priorities

Thorough due diligence uncovers issues that impact both EBITDA calculations and appropriate multiples:

• Financial audit: Verify historical statements and EBITDA calculations, examining revenue recognition policies, expense classifications, related-party transactions, and working-capital patterns.
• Physician stability: ASC value derives primarily from physician utilization, so review surgeon age demographics and succession planning, case-volume concentration (what percentage comes from the top three physicians?), retention history, and non-compete enforceability.
• Payer contract review: Analyze contract terms, rates, and renewal dates; change-of-control provisions; rate escalators; volume commitments; and in- vs. out-of-network status.
• Regulatory compliance: Confirm Medicare certification, state licensure and accreditation, Stark and Anti-Kickback compliance, HIPAA and data security, and employment compliance.

Deal Structure Considerations

How a transaction is structured significantly impacts effective valuation. Asset vs. stock purchases trade off depreciation step-up and liability protection against tax efficiency. Earnouts and contingent consideration based on EBITDA or revenue targets can bridge valuation gaps when buyer and seller disagree on future performance. Physician rollover equity aligns incentives and reassures buyers about physician commitment. And employment and service agreements — medical director agreements, physician contracts, and non-competes — protect physician continuity.

Minority Interest Valuation Challenges

Valuing minority interests presents unique challenges. Lack-of-control discounts (DLOC) may apply when valuing a minority interest by first determining control-level value and adjusting downward — though a direct minority valuation methodology may require little or no DLOC since the lack of control is already reflected in projected distributions. Lack-of-marketability discounts (DLOM) of 25–40% can apply because minority ASC interests cannot be quickly sold. When both apply, the combined discount can reach 45–60% — meaning a 20% minority interest in a $10 million ASC might be worth only $800,000–$1,100,000 rather than the $2,000,000 pro-rata calculation. Finally, buy-sell agreement terms may dictate valuation methods that override market-based conclusions.

The Value of Consulting Valuation Experts

Given the complexity and financial stakes involved, engaging experienced valuation professionals provides significant benefits for both buyers and sellers. Professional surgery center valuation reports become critical for transaction planning, tax and estate planning (IRS regulations require qualified appraisals), shareholder disputes, financial reporting, and SBA lending.

Not all business appraisers have the specialized knowledge required for surgery center valuation. Look for healthcare industry experience — appraisers who understand ASC operational nuances, the regulatory environment, and market dynamics — along with relevant professional credentials (such as the CVA — Certified Valuation Analyst), access to transaction data, and deep regulatory knowledge (Stark, Anti-Kickback, CON laws, CMS requirements).

To get the most from a professional engagement, provide complete information (financial statements, payer contracts, physician agreements, operational data), articulate the valuation’s purpose, ask questions about methodology and assumptions, and expect ranges rather than a single point estimate.

Need a credible, defensible ASC valuation? Nechay Advisors delivers thorough, well-supported appraisals for buy-ins, buyouts, disputes, and sales. Schedule a free consultation.

Conclusion

Surgery center valuation combines art and science, requiring both rigorous financial analysis and nuanced judgment about market conditions, operational quality, and strategic positioning. While EBITDA multiples provide the primary framework, successful valuations account for the dozens of factors that influence both sustainable earnings and the appropriate multiple.

Whether you’re a physician-owner contemplating selling your equity, an investor evaluating acquisition opportunities, or a health system considering ASC partnerships, understanding these principles empowers better decisions and more successful transactions. The centers that achieve premium valuations share common characteristics: strong operational performance, diversified revenue streams, stable physician relationships, and advantageous market positioning.

For specific guidance on your surgery center valuation needs, contact Nechay Advisors. We specialize in ASC and medical practice valuations, and work hard to deliver appraisals that are thorough, well-supported, and useful — whether you’re planning a transaction, resolving a dispute, or simply trying to understand what your interest is worth.

Frequently Asked Questions

What are surgery center valuation multiples?

Surgery center valuation multiples are financial ratios used to determine the market value of ambulatory surgery centers by comparing a financial metric (most commonly EBITDA) to the center’s enterprise value. They provide a standardized method for evaluating ASCs against comparable facilities and recent transaction data.

How are surgery center valuation multiples calculated?

Multiples are calculated by dividing the center’s value — expressed as Market Value of Invested Capital (MVIC) or Enterprise Value (EV) — by a financial metric, usually EBITDA. MVIC includes equity value plus interest-bearing debt and treats cash as an operating asset; Enterprise Value is similar but excludes cash. For example, a center that sells for $20 million on $3 million of EBITDA reflects a 6.67x EBITDA multiple.

Why are surgery center valuation multiples important?

Multiples provide a quick, standardized way to estimate ASC value and compare it to similar facilities. They let buyers and sellers establish reasonable price expectations based on actual market transactions rather than theoretical calculations, and they facilitate comparison across different sizes and specialties.

What factors influence surgery center valuation multiples?

Size and scale, specialty mix (single- vs. multi-specialty), payer relationships and in-network status, location and CON status, financial performance and growth trends, and physician stability all influence the multiple a center commands.

How do surgery center valuation multiples compare to other valuation methods?

Unlike discounted cash flow analysis (which projects future cash flows) or the cost approach (which estimates replacement value), multiples compare the ASC to similar entities based on current market conditions. Metrics like MVIC/EBITDA offer straightforward, market-based assessments that are practical for typical transactions, while DCF provides more nuanced insight for complex situations involving major growth initiatives.

What is the difference between in-network and out-of-network ASC valuations?

In-network centers with major commercial contracts generally command higher valuations because they offer predictable volume, reduced patient price sensitivity, lower collection costs, easier physician recruitment, and greater strategic value to buyers. Out-of-network centers may earn higher per-case reimbursement but face volume uncertainty and regulatory scrutiny that typically result in lower overall valuations.

Are there different types of surgery center valuation multiples?

Yes. MVIC/EBITDA is the most common (typically 2x–8x). MVIC/Revenue is less common but useful when EBITDA is distorted, MVIC/SDE is sometimes used for small physician-owned centers, and Price/Earnings is occasionally used but less relevant for ASCs. EBITDA multiples dominate because they best reflect operational performance independent of financing, tax, and accounting decisions.

How do single-specialty and multi-specialty centers compare in valuation?

Multi-specialty centers generally command higher multiples — for controlling interests, typically 6x–8x EBITDA vs. 5x–8x for single-specialty; for minority interests, 4x–6x vs. 3x–5x. The premium reflects diversification, revenue stability, broader procedural capabilities, and reduced vulnerability to specialty-specific reimbursement changes. That said, well-positioned single-specialty centers in high-margin specialties (like ophthalmology) can achieve comparable premium valuations.

What role does size play in surgery center valuation?

Size is one of the most significant drivers of multiples. Larger centers command higher multiples through economies of scale, a broader buyer universe (including institutional investors), better financing availability, platform-acquisition value, and reduced business risk from larger, more diverse patient volumes.

When should you hire a surgery center valuation expert?

Engage a professional for transaction planning, tax compliance (estate planning, charitable contributions, IRS-required appraisals), shareholder disputes, financial reporting, SBA financing, and strategic planning. The cost of a credible valuation is minimal compared to the financial stakes in most ASC transactions.

---

Alexey Nechay, CVA, is the principal of Nechay Advisors, a medical practice and surgery center valuation and brokerage firm in Newport Beach, California. Schedule a confidential call at (855) 955-2565.